title: Nephrotic syndrome in patients with peripheral blood stem cell transplant.
authors.affiliation: Department of Medicine, University of Michigan, Ann Arbor, MI 48103, USA. spandu@umich.edu
authors.forename: Panduranga S
authors.initials: PS
authors.lastname: Rao
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000528:radiation effects; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000150:complications; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000209:etiology; D006086:Graft vs Host Disease / Q000150:complications / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology*; D036102:Peripheral Blood Stem Cell Transplantation; D011183:Postoperative Complications / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D018805:Sepsis / Q000150:complications; D013203:Staphylococcal Infections / Q000150:complications; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D019172:Transplantation Conditioning / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D005047:Etoposide; D003520:Cyclophosphamide; D002066:Busulfan; D002330:Carmustine; D011241:Prednisone; D016559:Tacrolimus; D008727:Methotrexate